Recent drugs and vaccines candidates to tackle COVID-19

  • YOUSEFI M
  • CHEKANI-AZAR S
  • ABOUSENNA M
  • et al.
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Abstract

Introduction. The global devastating pandemic coronavirus disease 2019 (COVID-19) is a worldwide multisystemic infection caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged as a menace to the global public health and countries economy. There is a crucial necessity for the suggestion of effective drugs to eliminate the virus outbreak. Several candidate drugs with existing emerging evidence try to offer a pharmacological strategy that may inhibit infection in COVID-19 patients. By, October 2020, scientists have nominated some reliable and safe types of coronavirus vaccines like Pfizer, Moderna, AstraZeneca, CureVac, CoronaVac, etc. that are effective and showed 95% to 90% protection, respectively. Aim. This review highlights important clinical and in vitro studies, uses of potent antiviral drugs and most recent vaccines against COVID-19 disease.

Cite

CITATION STYLE

APA

YOUSEFI, M., CHEKANI-AZAR, S., ABOUSENNA, M. S., ARMIN, K., SHAVANDI, F., EMAMI, E., … GHARIB MOMBENI, E. (2020). Recent drugs and vaccines candidates to tackle COVID-19. Journal of Life Science and Biomedicine, 10(6), 70–79. https://doi.org/10.51145/jlsb.2020.9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free